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The exploration of potential utilization of microwaves as an energy source for heterocyclic synthesis
was herein investigated using condensation of 3-acetylcoumarin (1) with aromatic and heteroaromatic
aldehydes to afford the corresponding aromatic chalcones (2a–j) and heteroaromatic chalcones (3a–e
and 4a–e), respectively, in good to excellent yield within 1–3 min. The chemical structures were con-
firmed by analytical and spectral data. All the synthesized compounds were screened for their antibacte-
rial activity and 3-{3-(4-dimethylaminophenyl)acryloyl}-2H-chromen-2-one (2i) was discovered to be
the most active at minimum inhibitory concentration (MIC) value of 7.8 lg/mL.
J. Heterocyclic Chem., 47, 179 (2010).
INTRODUCTION
Over the years, coumarins have been established as
well-known naturally occurring oxygen-heterocyclic
compounds isolated from various plants [1–4]. They are
the family of lactones containing benzopyrone skeletal
framework that have enjoyed isolation from plant as
well as total synthesis in the laboratory. The plant
extracts containing coumarin-related heterocycles are
employed as herbal remedies in traditional systems of
medicine. The synthesis of coumarin (2-oxo-2H-chro-
mene) derivatives has attracted considerable attention of
organic and medicinal chemists due to its wide usage in
food additives [5], fragrances, pharmaceuticals, and
agrochemicals [6]. Furthermore, the pharmacological
and biochemical properties as well as therapeutic appli-
cations of coumarins depend upon the pattern of substi-
tution [7]. In view of this, coumarins have attracted
intense interest in recent years because of their diverse
pharmacological properties. Hence, coumarins have
been reported to possess, among others, anticoagulant
[8,9], antitubercular [10], antileucemic [11], antimicro-
bial [12,13], anti-inflammatory [14,15], anti-HIV [16],
analgesic [17,18], anticancer [19], antitumoral [20], anti-
convulsant [21,22], antiplatelet [23], antifungal [24,25]
antiviral [26,27], antibacterial [28–31], and antimalarial
[32] activities.
Some coumarin derivatives can be utilized benefi-
cially for the synthesis of valuable heterocyclic ring sys-
tems. In like fashion, chalcones are essential building
blocks [33] and valuable reactive intermediates for the
synthesis of various heterocyclic compounds [34–36] as
well as metal complexes [37–39] of high-biological rele-
vance. Many techniques have been employed in the syn-
thesis of coumarin frameworks [40,41] and chalcone
moieties [42,43]. However, microwave-assisted approach
toward the synthesis of coumarin chalcones has not
been extensively explored.
The continuing drive to develop more economical and
environmentally friendly chemical processes has spurred
synthetic chemists to seek more versatile methods such
as microwave method, for running reactions with less
waste and short reaction time [44,45]. On the basis of
the experimental data from various studies, chemists
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have found that microwave-enhanced chemical reaction
rates can be faster than those of conventional heating
methods by as much as a 1000-fold [46].
In view of our current trust in the microwave-assisted
organic synthesis [47] and various findings mentioned
earlier, there is merit in developing a facile route for the
formation of coumarins incorporated with chalcone tem-
plates via microwave synthetic approach to investigate
the antimicrobial properties of such targeted library.
RESULTS AND DISCUSSION
Chemistry. In a continuing effort to obtain new anti-
microbial drug candidates, the synthesis of s-phenyl-
and s-furan-2-ylcoumarin derivatives were attempted in
the presence of catalytic amount of piperidine in a sol-
vent less medium. 3-Acetylcoumarin, 1, used as the
essential precursor in this study, was synthesized by the
reaction of salisaldehyde with ethyl acetoacetate in
the presence of catalytic amount of piperidine (Scheme 1).
Furthermore, 3-acetylcoumarin, 1 was made to undergo
condensation reaction with substituted benzaldehdye to
afford chalcones 3-{3-(s-aryl)acryloyl)}-2H-chromen-2-
one, 2a–i, whereas the replacement of benzaldehyde with
cinnamaldehyde resulted in the formation of chalcone 3-
(5-phenylpenta-2,4-dienoyl)-2H-chromen-2-one 2j under
microwave irradiation (Scheme 2). The reaction of 1 with
heteroaromatic aldehyde; furfural and pyrrole-2-carbalade-
hyde furnished chalcones 3-{3-(s-heteroaromatic) acryl-
oyl)}-2H-chromen-2-one 3a–e and 4a–e, respectively
(Scheme 3) in moderate yields.
Preliminary optimization of reaction conditions was
done by comparing the synthesis of 2a in the presence
of two solvents and solvent-free media (Table 1). It was
observed that the solvent free medium gave the most
suitable condition for the synthesis of 2a, and therefore,
it was used in all subsequent experiments. The effect of
temperature was studied by carrying out the synthesis of
2a at different temperatures; 50, 100, and 140C (Table
2) using neat reaction condition in solvent free media. It
was discovered that yield is a function of temperature,
since the yield increased as the reaction temperature
was raised. In fact, 2a had the highest yield (97%) at
140C. The results show that neat preparation of 2a in
solvent free medium at 140C provides an efficient way
to access diverse, highly functionalized coumarin con-
taining chalcones. Hence, these optimum conditions
were applied for the synthesis of a series of 3-{3-(s-aryl
and (s-heteroaryl)acryloyl}-2H-chromen-2-one deriva-
tives 2a–j, 3a–e, and 4a–e, respectively. The melting
points of the compounds varied between 119 and 289C
for all the compounds except 3c and 4e which did not
melt even at 300C. The progress of the reaction was
monitored by TLC spotting with Rf values ranging
between 0.44 and 0.85 in acetone/methanol (3:1, v/v)
solvent system.
The structures of newly synthesized compounds were
elucidated by IR, UV, NMR, mass spectral studies, and
elemental analysis. The IR spectrum, of 2a, for instance,
exhibited the absorption band at 1740 cm1 due to the
presence of C¼O (ester) which was confirmed by the
presence of CAO of lactone at 1363 cm1. The band at
1673 cm1 and 1606 cm1 depicted the presence of
C¼O (conjugated ketone) and C¼C (aromatic), respec-
tively. The UV–visible spectrum of 2a gave rise to
wavelength (kmax) at 224 nm and 348 nm with log e
Scheme 1. Microwave assisted synthesis of 3-acetylcoumarin, 1.
Scheme 2. Microwave assisted synthesis of various s-arylchalcones, 2a–j.
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values of 3.99 and 3.47, respectively, whereas a
shoulder was observed at 375 nm. The wavelength at
224 nm was as a result of p!p* transition of phenyl
ring, whereas 348 nm was as a result of n!p* transition
of the enone attached to coumarin moiety at 3-position,
whereas a bathochromic shift observed as a shoulder at
375 nm was due to the presence of extensive conjuga-
tion of the p-electron systems. In 1H-NMR spectrum
(CD3OD) of 2a, a doublet at d 7.03 (1H, J ¼ 8.5 Hz,
COACH¼C); a multiplet at d 7.33–7.84 (9H, which
was made up of four protons of benzofused coumarin
and five phenyl protons); a doublet at d 7.82 (1H, J ¼
8.5 Hz, COAC¼CH) and a singlet at d 8.57 (1H, Cou-
marin-H) were all observed down field of TMS scale.
The 13C-NMR spectrum showed peaks at d 183.7 ppm
due to C¼O (conjugated ketone), whereas the peak at d
159.4 ppm was due to the presence of C¼O (ester).
Other peaks which were observed between d 153.0 and
116.1 ppm were due to sixteen sp2 hybridized carbon
atoms. The mass spectrum of 2a showed the molecular
ion peak at m/z 276 corresponding to its molecular
weight. The base peak was observed at 173, whereas
other daughter fragment noticed at m/z 199 was due to
loss of phenyl free radical. The result of elemental anal-
ysis (Table 3) did not only correlate well with the mo-
lecular masses of the compounds but also showed a con-
sistent minimum difference of not more than 60.40
between % calculated and % found for the carbon,
hydrogen, and nitrogen of the prepared compounds.
Antibacterial activities. The antibacterial activity of
21 synthesized compounds, 1–4e, was determined in
vitro by agar well diffusion technique [48]. The media
were inoculated with test organisms and a solution of
the tested compound in DMSO solvent. The zones of in-
hibition were measured after 24 h of incubation. The in
vitro general sensitivity testing of the prepared com-
pounds, 1–4e was carried out against five gram positive
bacteria [Bacillus anthracis (LIO), Bacillus stearother-
mophilus (NCIB 8222), Bacillus subtilis (NCIB 3610),
Bacillus cereus (NCIB 6349), Staphylococcus aureus
(NCIB 8588)] and five gram negative bacteria [Esche-
richia coli (NCIB 86), Klebsiella pneumonia (NCIB
418), Pseudomonas aeruginosa (NCIB 950), Pseudomo-
nas fluorescence (NCIB 3756), Shigella dysenteriae
(LIO)] as well as the standard drug streptomycin (Table
4). It was observed that the zones of inhibition of 1, 2a,
2d, 2f, 2g on growth of various bacteria varied between
10 mm and 23 mm, whereas that of 2b, 2c, 2j, 3a, 4c
was between 10 mm and 21 mm. Others include 3b, 3d,
4d, 4e with zones of inhibition of 11–23 mm and 2e, 2i,
3c, 4a with inhibition zones of 15–31 mm.
In like fashion, the zones of inhibition of 2h on the
bacteria growth ranged between 14 mm and 18 mm,
whereas that of 3e ranged between 14 mm and 22 mm.
Furthermore, streptomycin standard was active on all
bacteria with the zones of inhibition ranging from 17
mm to 28 mm, except on E. coli, Klebsiella pneumoniae
and Pseudomonas aeruginosa where resistance was
noticed. Compared with streptomycin, compounds 2e,
2i, and 4a revealed larger zones of inhibition against
Bacillus stearothermophilus (i.e., >23 mm) and Bacillus
subtilis (i.e., >27 mm), whereas 2d and 4e showed the
same zones of inhibition as streptomycin upon Bacillus
cereus (23 mm).
However, high degree of resistance as well as small
zones of inhibition were observed upon the screening of
synthesized compounds against Bacillus cereus, Staphy-
lococcus aureus, Pseudomonas aeruginosa, Pseudomo-
nas fluorescence, and Shigella dysenteriae. In view of
these, minimum inhibitory concentration (MIC) and
minimum bactericidal concentration (MBC) tests were
selectively carried out on the remaining five
Scheme 3. Microwave assisted synthesis of various s-heteroaromatic chalcones, 3a–e and 4a–e.
Table 1
Synthesis of 3-cinnamoyl-2H-chromen-2-one, 2a, in different
solvents at 140C.
Entry Solvent Time/mins Yield/%
1 Ethanol 1 52
2 Chloroform 1 45
3 Solvent free 1 97
Table 2
Synthesis of 3-cinnamoyl-2H-chromen-2-one, 2a, at different
temperatures.
Entry Solvent Temperature/C Yield/%
1 Solvent free 140 97
2 Solvent free 100 83
3 Solvent free 50 58
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Table 3
Physicochemical properties of compounds synthesized (1–4e).
Comp no. Molecular formula Mol. wt. Yield (%) M.P. (C) Rf
a Color
Elem. Anal. %Calcd. (%Found)
C H N
1 C11H8O3 188 92.6 119–121 0.52 yellow 70.2(70.1) 4.3(4.4) –
2a C18H12O3 276 97.0 142–143 0.50 yellow 78.3(78.1) 4.3(4.5) –
2b C18H12O4 292 89.1 139–140 0.61 yellow 74.0(74.4) 4.1(3.9) –
2c C18H11NO5 321 78.3 170–172 0.69 orange 67.3(67.2) 3.4(3.2) 4.4(4.6)
2d C18H11ClO3 310.5 77.1 222–223 0.59 yellow 69.7(69.4) 3.5(3.7) –
2e C19H14O3 290 92.5 161–163 0.54 yellow 78.6(78.3) 4.8(4.5) –
2f C20H16O3 304 95.1 172–174 0.66 cream 78.9(78.6) 5.3(5.1) –
2g C18H12O4 292 97.8 246–249 0.68 yellow 74.0(73.8) 4.1(4.3) –
2h C19H14O5 322 77.1 230–231 0.70 yellow 70.8(70.9) 4.3(4.1) –
2i C20H17NO3 319 81.6 217–218 0.71 red 75.2(74.9) 5.3(5.0) 4.4(4.7)
2j C20H14O3 302 73.3 184–186 0.63 yellow 79.5(79.3) 4.6(4.4) –
3a C16H10O4 266 87.2 135–137 0.57 brown 72.2(72.4) 3.8(3.5) –
3b C16H9NO6 311 66.8 194–196 0.81 yellow 61.7(61.4) 2.9(3.1) 4.5(4.3)
3c C16H9ClO4 300.5 59.2 > 300 0.44 green 63.9(64.1) 3.0(2.8) –
3d C17H12O4 280 74.8 200–201 0.49 green 72.9(72.6) 4.3(4.5) –
3e C18H14O4 294 66.5 240–241 0.85 orange 73.5(73.8) 4.8(4.7) –
4a C16H11NO3 265 71.4 209(dec) 0.69 black 72.5(72.4) 4.2(4.4) 5.3(5.5)
4b C16H10N2O5 310 63.7 268–269 0.85 yellow 61.9(62.2) 3.2(3.3) 9.0(9.2)
4c C16H10NClO3 299.5 55.8 288–289 0.55 yellow 64.1(61.5) 3.3(3.5) 4.7(4.5)
4d C17H13NO3 279 50.1 214–216 0.77 orange 73.1(73.5) 4.7(4.6) 5.0(4.8)
4e C18H15NO3 293 50.8 > 300 0.83 yellow 73.7(73.3) 5.1(5.0) 4.8(4.6)
a Solvent system: CH3COCH3:CH3OH (3:1, v/v) solvent system.
Table 4
Result of antibacterial screening (sensitivity testing) on bacteria with zones of inhibition (in mm).
Comp. no.
Bacteria
B.a B.c B.s B.su S.a E.c K.p P.a P.f S.d
1 10 10 11 23 – 14 12 13 10 –
2a – 14 18 20 – 10 23 – 10 –
2b – – 20 – – 17 19 – – –
2c 12 – – 21 14 10 16 – – –
2d 17 23 23 16 10 14 – 16 – –
2e 18 20 24 31 18 16 29 21 15 18
2f 21 15 – 23 – 15 19 11 10 –
2g – – 20 23 – 18 10 – – –
2h 18 18 15 11 – 16 14 – – –
2i 18 25 25 28 – 31 22 17 – 15
2j – 10 20 20 – 21 16 – 12 18
3a – – 14 10 10 21 17 – – –
3b 11 8 – 11 – 19 23 – – –
3c – – 15 19 – 31 18 15 – –
3d 13 – 12 18 – 17 23 15 13 11
3e 15 – 20 14 15 13 22 17 – –
4a 18 – 31 28 – 16 15 – – –
4b 12 – – 13 – 9 15 12 – –
4c 18 – 12 15 13 21 13 13 – 10
4d 15 13 16 14 – 14 23 – – 11
4e 17 23 22 – – 13 – 11 – –
str 20 23 23 27 21 – – – 22 17
–Indicates bacteria are resistant to the compounds >1000 lg/mL.
B.a, Bacillus anthracis (LIO)Gþ; B.c, Bacillus cereus (NCIB 6349)Gþ; B.s, Bacillus stearothermophilus (NCIB 8222)Gþ; B.su, Bacillus subtilis
(NCIB 3610)Gþ; S.a, Staphylococcus aureus (NCIB 8588)Gþ; E.c, Escherichia coli (NCIB 86)G; K.p, Klebsiella pneumonia (NCIB 418)G; P.a,
Pseudomonas aeruginosa (NCIB 950)G; P.f, Pseudomonas fluorescence (NCIB 3756)G; S.d, Shigella dysenteriae (LIO)G; str, streptomycin;
Gþ, Gram positive; G, Gram negative.
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microorganisms comprising three gram þve (Bacillus
anthracis, Bacillus subtilis, and Bacillus stearothermo-
philus) and two gram –ve (Escherichia coli and Kleb-
siella pneumoniae) bacterial strains (Table 5). MIC is
defined as the lowest concentration of the compounds
that completely inhibit the growth of microorganism,
whereas MBC is the lowest concentration at which
99.9% of the inoculum was killed. The MIC values of
the compounds varied between 7.8 and 31.2 lg/mL,
whereas that of streptomycin was between 7.8 and 15.6
lg/mL. The MBC of few compounds was found to be
the same as MIC but in most of the compounds, it was
twofold or threefold or fourfold higher than their corre-
sponding MIC values. In the long run, 2i emerged as
the most active antibacterial agent at 7.8 lg/mL.
CONCLUSIONS
It was discovered that microwave-assisted approach is
highly efficient procedure for the preparation of various
coumarin chalcones, especially in the solvent-free
media. By visualizing the antimicrobial data, the results
revealed that the compounds exhibited high potency as
antibacterial agents. The most active compound was
3-{(3-(4-dimethylamino phenyl)acryloyl}-2H-chromen-
2-one (2i) with an MIC value of 7.8 lg/mL. Thus, 3-
(substituted aryl and substituted heteroaromatic)acry-
loyl)-2H-chromen-2-one derivatives synthesized as well
as the starting material may seem promising for further
activity optimization studies.
EXPERIMENTAL
General condition (chemical synthesis). Melting points
were determined with open capillary tube on a Gallenkamp
(variable heater) melting point apparatus and were uncorrected.
Infra red spectra were recorded as KBr disc using a Shimadzu
IR-740 Spectrophotometer, whereas UV–visible spectra were
recorded on a Hekiosea v2.02 Unicam Spectrophotometer
using methanol solvent. 1H- and 13C-NMR were run on a Jeol
EX 400 Spectrometer using deuteriated methanol with tetrame-
thylsilane as the internal standard and d values recorded in
ppm. Mass spectra were run on Finnigan MAT 312 machine.
All compounds were routinely checked by TLC on silica gel
G plates using CH3COCH3:CH3OH (3:1, v/v) solvent system
and the developed plates were visualized under UV light. The
elemental analysis (C, H, N) of compounds were performed
using a Carlo Erba-1108 elemental analyzer. The microwave-
assisted syntheses were carried out in a CEM Discover mono-
mode oven using sealed tube, with magnetic stirring, and the
temperature control was fixed at 140C. All reagents used
Table 5
Results of MIC and MBC of synthesized compounds on some selected bacteria (in lg/mL).
Bacteria
B. anthracis B. stearotherm B. subtilis E. coli K. pneumonia
Comp. no. MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
1 31.2 62.4 31.2 62.4 15.6 15.6 31.2 31.2 31.2 31.2
2a – – 15.6 15.6 7.8 7.8 31.2 62.4 7.8 31.2
2b – – 7.8 31.2 – – 15.6 15.6 7.8 15.6
2c 31.2 62.4 – – 7.8 7.8 31.2 62.4 15.6 62.4
2d 15.6 62.4 7.8 31.2 15.6 15.6 15.6 31.2 – –
2e 7.8 15.6 7.8 15.6 7.8 7.8 15.6 31.2 7.8 31.2
2f 7.8 31.2 – – 7.8 7.8 15.6 15.6 15.6 62.4
2g – – 7.8 7.8 7.8 7.8 15.6 15.6 31.2 62.4
2h 15.6 15.6 15.6 62.4 31.2 31.2 31.2 31.2 31.2 63.4
2i 7.8 7.8 7.8 15.6 7.8 7.8 7.8 7.8 7.8 7.8
2j – – 15.6 62.4 7.8 7.8 7.8 15.6 15.6 31.2
3a – – 31.2 31.2 31.2 31.2 7.8 7.8 7.8 15.6
3b 31.2 62.4 – – 31.2 31.2 15.6 15.6 15.6 15.6
3c – – 31.2 93.6 7.8 7.8 7.8 7.8 15.6 31.2
3d 31.2 62.4 31.2 31.2 15.6 15.6 15.6 31.2 7.8 15.6
3e 15.6 31.2 7.8 15.6 31.2 62.4 31.2 62.4 7.8 31.2
4a 7.8 31.2 7.8 7.8 7.8 31.2 15.6 62.4 31.2 62.4
4b 31.2 31.2 – – 15.6 31.2 31.2 31.2 7.8 15.6
4c 7.8 15.6 31.2 31.2 15.6 15.6 7.8 31.2 31.2 93.6
4d 15.6 62.6 15.6 31.2 15.6 31.2 15.6 15.6 7.8 31.2
4e 15.6 31.2 7.8 15.6 – – 31.2 31.2 – –
str 7.8 15.6 15.6 15.6 7.8 7.8 – – – –
– Indicates bacteria are resistant to the compounds >100 lg/mL.
MIC, minimum inhibitory concentration, i.e. the lowest concentration to completely inhibit bacterial growth; MBC, minimum bactericidal concen-
tration, i.e. the lowest concentration to completely kill bacteria.
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were obtained from Sigma-Aldrich Chemicals, except piperi-
dine and furfural derivatives which were obtained from BDH
Chemical Limited. Solvents used were of analytical grade and,
when necessary, were purified and dried by standard method.
3-Acetylcoumarin (1). To a mixture of salicyaldehyde
(0.86 mL, 81.89 mmoles) and ethyl acetoacetate (11.5mL,
90.13 mmoles) was added catalytic amount of piperidine (0.2
mL, 1.64 mmoles) and swirled thoroughly. The mixture was
irradiated in microwave oven at 400 W for 1 min. The solid
product was filtered, dried, and recrystallized from methanol to
afford pure 3-acetyl coumarin 1 in appropriate yield (Table 3).
kmax (Log e): 216 (5.29), 236 (4.65), 288 (4.57), 327 (4.57),
348 (4.49), 355 (4.24), 369 (4.01). IR (KBr): 2925 (CH ali-
phatic), 1746 (C¼O ester), 1685 (C¼O), 1606 (C¼C), 1369
cm1. 1H-NMR (CD3OD, 400 Hz): d 2.27 (s, 3H, CH3), 7.42–
7.84 (m, 4H, Benzofused coumarin-H), 8.57 (s, 1H, Coumarin-
H). 13C-NMR (CD3OD, 400 Hz): d 198.7 (C¼O), 159.4
(C¼O), 153.0, 137.4, 131.2, 128.3, 127.9, 125.4, 118.1, 116.1,
29.6 (CH3) ppm. MS: m/z 188 (M
þ, 80%), 145 (100%), 94
(50%).
General procedure for synthesis of (2a–j). To an equimo-
lar mixture of 3-acetylcoumarin, 1 (1 g, 5.3 mmoles) and sub-
stituted benzaldehyde (5.3 mmoles) was added piperidine (0.2
mL, 1.64 mmoles) drop wisely with continuous stirring until
homogeneity was achieved. The mixture was irradiated in
microwave oven at 400 W for 1–3 min. The crude product
was filtered, dried, and recrystallized from appropriate solvent
to afford 2a–j in varied yields (Table 3).
3-Cinnamoyl-2H-chromen-2-one (2a). Reagents: Compound
1 (1.0 g, 5.3 mmoles), benzaldehyde (0.5 mL, 5.3 mmoles), pi-
peridine (0.2 mL). Conditions: MWI for 3 min, 140C. Purifi-
cation: recrystallization (ethanol). kmax (Log e): 224 (3.99),
348 (3.47), 375 (3.01s). IR (KBr): 1740, 1673, 1606, 1363
cm1. 1H-NMR (CD3OD, 400 Hz): d 7.03 (d, 1H, J ¼ 8.5 Hz,
COACH¼C), 7.33–7.84 (m, 9H, Benzofused coumarin-4H
and Ar-5H), 7.82 (d, 1H, J ¼ 8.5 Hz, COAC¼CH), 8.57 (s,
1H, Coumarin-H). 13C-NMR (CD3OD, 400 Hz): d 183.7
(C¼O), 159.4 (C¼O), 153.0, 147.2, 142.2, 135.2, 134.2,
128.6, 128.6, 128.5, 128.5, 128.3, 127.9, 127.9, 125.4, 125.4,
118.1, 116.1 ppm. MS: m/z 276 (Mþ, 75%), 199 (60%), 173
(100%).
3-(3-(3-Hydroxyphenyl)acryloyl)-2H-chromen-2-one (2b). Reagents:
Compound 1 (1.0 g, 5.3 mmoles), m-hydroxybenzaldehyde
(0.65 g, 5.3 mmoles), piperidine (0.2 mL). Conditions: MWI
for 2 min, 140C. Purification: recrystallization (methanol).
kmax (Log e): 208 (3.82), 280 (3.32), 348 (3.46), 361 (3.46),
369 (3.45). IR (KBr): 3302, 1703, 1648, 1600, 1375 cm1. 1H-
NMR (CD3OD, 400 Hz): d 5.35 (s, 1H, OH, D2O exchange-
able), 6.70 (s, 1H, Ar-H), 6.83 (d, 1H, Ar-H), 7.03 (d, 1H, J ¼
8.8 Hz, COACH¼C), 7.16 (d, 1H, Ar-H), 7.42–7.84 (m, 4H,
Benzofused coumarin-H), 7.53 (t, 1H, Ar-H), 7.96 (d, 1H, J ¼
8.8 Hz, COAC¼CH), 8.57 (s, 1H, Coumarin-H). 13C-NMR
(CD3OD, 400 Hz): d 183.7 (C¼O), 159.4 (C¼O), 158.4,
153.0, 147.2, 142.2, 135.4, 134.2, 130.0, 128.3, 127.9, 125.4,
125.4, 121.1, 118.1, 117.6, 116.1, 115.1 ppm. MS: m/z 292
(Mþ, 30%), 275 (50%), 199 (25%), 145 (100%).
3-(3-(4-Nitrophenyl)acryloyl)-2H-chromen-2-one (2c). Reagents:
Compound 1 (1.0 g, 5.3 mmoles), p-nitrobenzaldehyde (0.80 g,
5.3 mmoles), piperidine (0.2 mL). Conditions: MWI for 1 min,
140C. Purification: recrystallization (methylated spirit). kmax
(Log e): 220 (4.22), 328 (3.76), 368 (3.87). IR (KBr): 1740,
1673, 1606, 1364, 738 cm1. 1H-NMR (CD3OD, 400 Hz): d
7.32 (d, 1H, J ¼ 8.5 Hz, COACH¼C), 7.96 (d, 1H, J ¼ 8.5
Hz, COAC¼CH), 7.42–7.84 (m, 4H, Benzofused coumarin-
H), 8.03 (d, 2H, Ar-H), 8.21 (d, 2H, Ar-H), 8.57 (s, 1H, Cou-
marin-H). 13C-NMR (CD3OD, 400 Hz): d 183.7 (C¼O), 159.4
(C¼O), 153.0, 147.2, 147.1, 142.2, 141.3, 134.2, 129.0, 129.0,
128.3, 127.9, 125.4, 125.4, 123.8, 123.8, 118.1, 116.1 ppm.
MS: m/z 321 (Mþ, 70%), 275 (47%), 145 (100%).
3-(3-(4-Chlorophenyl)acryloyl)-2H-chromen-2-one (2d). Reagents:
Compound 1 (1.0 g, 5.3 mmoles), p-chlorobenzaldehyde (0.74
g, 5.3 mmoles), piperidine (0.2 mL). Conditions: MWI for 1.5
min, 140C. Purification: recrystallization (methanol). 1H-
NMR (CD3OD, 400 Hz): d 7.03 (d, 1H, J ¼ 8.5 Hz,
COACH¼C), 7.82 (d, 1H, J ¼ 8.5 Hz, COAC¼CH), 7.44 (d,
2H, Ar-H), 7.68 (d, 2H, Ar-H), 7.42–7.84 (m, 4H, Benzofused
coumarin-H), 8.57 (s, 1H, Coumarin-H). 13C-NMR (CD3OD,
400 Hz): d 183.7, 159.4, 153.0, 147.2, 142.2, 134.2, 133.5,
133.3, 129.0, 129.0, 128.7, 128.7, 128.3, 127.9, 125.4, 125.4,
118.1, 116.1 ppm. MS: m/z 310.5 (Mþ, 80%), 275 (40%).
3-(3-(3-p-Tolylacryloyl)-2H-chromen-2-one (2e). Reagents:
Compound 1 (1.0 g, 5.3 mmoles), p-methylbenzaldehyde (0.65
g, 5.3 mmoles), piperidine (0.2 mL). Conditions: MWI for 2
min, 140C. Purification: recrystallization (methanol). 1H-
NMR (CD3OD, 400 Hz): d 2.34 (s, 3H, CH3), 7.18 (d, 2H, Ar-
H), 7.03 (d, 1H, J ¼ 8.5 Hz, COACH¼C), 7.42–7.84 (m, 4H,
Benzofused coumarin-H), 7.59 (d, 2H, Ar-H), 7.82 (d, 1H, J ¼
8.5 Hz, COAC¼CH), 8.57 (s, 1H, Coumarin-H). 13C-NMR
(CD3OD, 400 Hz): d 183.7, 159.4, 153.0, 147.2, 142.2, 137.6,
134.2, 132.2, 128.9, 128.9, 128.5, 128.5, 128.3, 127.9, 125.4,
125.4, 118.1, 116.1, 21.3 (CH3) ppm. MS: m/z 290 (M
þ,
50%), 199 (100%).
3-(3-(4-Ethylphenyl)acryloyl)-2H-chromen-2-one (2f). Reagents:
Compound 1 (1.0 g, 5.3 mmoles), p-ethylbenzaldehyde (0.72
mL, 5.3 mmoles), piperidine (0.2 mL). Conditions: MWI for 2
min, 140C. Purification: recrystallization (methanol). 1H-
NMR (CD3OD, 400 Hz): d 1.25 (t, 3H, J ¼ 7.0 Hz, CH3),
2.60 (q, 2H, J ¼ 7.0 Hz, CH2), 6.77 (d, 2H, Ar-H), 7.03 (d,
1H, J ¼ 8.5 Hz, COACH¼C), 7.42–7.84 (m, 6H, Benzofused
coumarin-4H and Ar-2H), 7.82(d, 1H, J ¼ 8.5 Hz,
COAC¼CH), 8.57 (s, 1H, Coumarin-H). 13C-NMR (CD3OD,
400 Hz): d 183.7, 159.4, 153.0, 142.2, 143.5, 142.2, 134.2,
132.4, 128.5, 128.5, 128.3, 127.9, 127.6, 127.6, 125.4, 125.4,
118.1, 116.1, 28.2 (CH2), 14.5 (CH3). MS: m/z 304 (M
þ,
80%), 285 (35%), 145 (100%).
3-(3-(4-Hydroxyphenyl)acryloyl)-2H-chromen-2-one (2g). Reagents:
Compound 1 (1.0 g, 5.3 mmoles), p-hydroxybenzaldehyde
(0.65 g, 5.3 mmoles), piperidine (0.2 mL). Conditions: MWI
for 3 min, 140C. Purification: recrystallization (ethanol). kmax
(Log e): 211 (3.52), 336 (3.41), 368 (3.56). IR (KBr): 3241,
1734, 1685, 1612, 1375 cm1. 1H-NMR (CD3OD, 400 Hz): d
5.35 (s, 1H, OH, D2O exchangeable), 6.65 (d, 2H, Ar-H), 7.03
(d, 1H, J ¼ 8.5 Hz, COACH¼C), 7.42–7.84 (m, 4H, Benzo-
fused coumarin-H), 7.56 (d, 2H, Ar-H), 7.82 (d, 1H, J ¼ 8.5
Hz, COAC¼CH), 8.57 (s, 1H, Coumarin-H). 13C-NMR
(CD3OD, 400 Hz): d 183.7, 159.4, 157.7 (CAOH), 153.0,
147.2, 142.2, 134.2, 130.6, 130.6, 128.3, 127.9, 127.8, 125.4,
125.4, 118.1, 116.1, 115.8 ppm. MS: m/z 292 (Mþ, 40%), 275
(75%), 199 (50%), 145 (100%).
3-(3-(4-Hydroxy-3-methoxyphenyl)acryloyl)-2H-chromen-2-
one (2h). Reagents: Compound 1 (1.0 g, 5.3 mmoles), vanillin
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(0.81 g, 5.3 mmoles), piperidine (0.2 mL). Conditions: MWI
for 1 min, 140C. Purification: recrystallization (ethanol). kmax
(Log e): 208 (4.03), 244 (3.91), 352 (3.42). IR (KBr): 1740,
1685, 1600, 1338 cm1. 1H-NMR (CD3OD, 400 Hz): d 3.83
(s, 3H, OCH3), 5.35 (s, 1H, OH, D2O exchangeable), 6.79 (d,
1H, Ar-H), 6.99 (d, 1H, Ar-H), 7.03 (d, 1H, J ¼ 8.5 Hz,
COACH¼C), 7.16 (s, 1H, Ar-H), 7.42–7.84 (m, 4H, Benzo-
fused coumarin-H), 7.82 (d, 1H, J ¼ 8.5 Hz, COAC¼CH),
8.57 (s, 1H, Coumarin-H). 13C-NMR (CD3OD, 400 Hz): d
183.7 (C¼O), 159.4 (C¼O), 153.0, 149.1 (CAOCH3), 147.9
(CAOH), 147.2, 142.2, 134.2, 128.3, 127.9, 127.6, 125.4,
125.4, 122.9, 118.1, 116.8, 116.1, 111.9, 56.1 (OCH3) ppm.
MS: m/z 323 (Mþ, 68%), 275 (60%), 199 (50%).
3-(3-(4-Dimethylaminophenyl)acryloyl)-2H-chromen-2-one
(2i). Reagents: Compound 1 (1.0 g, 5.3 mmoles), 4-(N,N-
dimethylamino)benzaldehyde (1.27 g, 5.3 mmoles), piperidine
(0.2 mL). Conditions: MWI for 2.5 min, 140C. Purification:
recrystallization (ethanol). kmax (Log e): 208 (4.00), 327
(3.90s), 344 (3.97), 448 (3.84). IR (KBr): 1746, 1685, 1594,
1375 cm1. 1H-NMR (CD3OD, 400 Hz): d 3.06 (s, 6H,
2CH3), 6.71 (d, 2H, Ar-H), 7.03 (d, 1H, J ¼ 8.5 Hz,
COACH¼C), 7.72 (d, 2H, Ar-H), 7.42–7.84 (m, 4H, Ar-H),
7.82 (d, 1H, J ¼ 8.5 Hz, COAC¼CH), 8.57 (s, 1H, Couma-
rin-H). 13C-NMR (CD3OD, 400 Hz): d 183.7 (C¼O), 159.4
(C¼O), 153.0, 150.3, 147.2, 142.2, 134.2, 129.7, 129.7, 128.3,
127.9, 125.4, 125.4, 124.7, 118.1, 116.1, 111.7, 111.7, 41.3
(2CH3) ppm. MS: m/z 319 (Mþ, 70%), 199 (100%).
3-(5-Phenylpenta-2,4-dienoyl)-2H-chromen-2-one (2j). Reagents:
Compound 1 (1.0 g, 5.3 mmoles), cinnamaldehyde (0.67 mL,
5.3 mmoles), piperidine (0.2 mL). Conditions: MWI for 1 min,
140C. Purification: recrystallization (ethanol). kmax (Log e):
212 (3.72), 300 (3.49), 330 (3.49), 347 (3.53), 360 (3.53), 366
(3.53), 369 (4.01). IR (KBr): 1740, 1648, 1612, 1375 cm1.
1H-NMR (CD3OD, 400 Hz): d 6.69 (d, 1H, J ¼ 8.5 Hz,
COACH¼C), 6.71 (d, 1H, J ¼ 8.5 Hz, 9.2 Hz,
COAC¼CACH), 7.02 (d, 1H, J ¼ 9.2 Hz, COC¼CAC¼CH),
7.52 (d, 1H, J ¼ 8.5 Hz, 9.2 Hz, COAC¼CH), 7.33–7.84 (m,
9H, Benzofused coumarin-4H and Ar-5H), 8.57 (s, 1H, Cou-
marin-H). 13C-NMR (CD3OD, 400 Hz): d 183.7 (C¼O), 159.4
(C¼O), 153.0, 151.9, 147.2, 141.0, 135.2, 134.2, 128.6, 128.6,
128.5, 128.5, 128.3, 127.9, 127.9, 125.4, 125.2, 121.2, 118.1,
116.1 ppm. MS: m/z 302 (Mþ, 55%).
General procedure for synthesis of (3a–e) and (4a–e). A
catalytic amount of piperidine (0.2 mL, 1.64 mmoles) was cau-
tionly added to a well-ground mixture of 3-acetyl coumarin
1(1.0 g, 5.3 mmoles) and substituted heteroaromatic aldehyde
(5.3 mmoles). The reaction mixture was irriadiated in micro-
wave oven at an emitted power of 400 W for an appropriate
time. Then, it was poured in crushed ice and the product was
filtered and recrystallized from appropriate solvent to give 3a–
e and 4a–e.
3-(3-(Furan-2-yl)acryloyl)-2H-chromen-2-one (3a). Reagents:
Compound 1 (1.0 g, 5.3 mmoles), furfural (0.33 mL, 5.3
mmoles), piperidine (0.2 mL). Conditions: MWI for 3 min,
140C. Purification: recrystallization (methylated spirit). kmax
(Log e): 220 (3.88), 348 (3.49), 368 (3.65). IR (KBr): 1734,
1648, 1606, 1380 cm1. 1H-NMR (CD3OD, 400 Hz): d 6.87
(t, 1H, Furan-H), 7.03 (d, 1H, J ¼ 8.7 Hz, COACH¼C),
7.42–7.84 (m, 5H, Benzofused coumarin-4H & Furan-1H),
7.66 (d, 1H, J ¼ 8.7 Hz, COAC¼CH), 8.17 (d, 1H, Furan-H),
8.57 (s, 1H, Coumarin-H). 13C-NMR (CD3OD, 400 Hz): d
183.7 (C¼O), 159.4 (C¼O), 153.0, 151.5, 147.2, 143.7, 138.9,
134.2, 129.3, 128.3, 127.9, 125.4, 118.1, 116.1, 113.8, 112.7.
MS: m/z 266 (Mþ, 25%), 199 (75%), 68 (33%).
3-(3-(5-Nitrofuran-2-yl)acryloyl)-2H-chromen-2-one (3b). Reagents:
Compound 1 (1.0 g, 5.3 mmoles), 5-nitrofurfural (0.47 mL,
5.3 mmoles), piperidine (0.2 mL). Conditions: MWI for 1.5
min, 140C. Purification: recrystallization (aqueous ethanol,
1:1). kmax (Log e): 216 (4.03), 372 (3.77). IR (KBr): 1734,
1685, 1600, 1376 cm1. 1H-NMR (CD3OD, 400 Hz): d 7.03
(d, 1H, J ¼ 8.7 Hz, COACH¼C), 7.42–7.85 (m, 5H, Benzo-
fused coumarin-4H & Furan-1H), 7.66 (d, 1H, J ¼ 8.7 Hz,
COAC¼CH)), 7.94 (d, 1H, Furan-H), 8.57 (s, 1H, Coumarin-
H). 13C-NMR (CD3OD, 400 Hz): d 183.7 (C¼O), 159.4
(C¼O), 155.4, 153.8, 153.0, 147.2, 138.9, 134.2, 129.3, 128.3,
127.9, 125.4, 118.1, 117.5, 116.1, 114.5. MS: m/z 311 (Mþ,
20%), 265 (45%).
3-(3-(5-Chlorofuran-2-yl)acryloyl)-2H-chromen-2-one (3c). Reagents:
Compound 1 (1.0 g, 5.3 mmoles), 5-chlorofurfural (0.69 g, 5.3
mmoles), piperidine (0.2 mL). Conditions: MWI for 1 min,
140C. Purification: recrystallization (ethanol). kmax (Log e):
216 (4.28), 368 (4.41), 388 (3.95). IR (KBr): 1744, 1648,
1605, 1380 cm1. 1H-NMR (CD3OD, 400 Hz): d 6.89 (d, 1H,
J ¼ 9.3 Hz, Furan-H), 7.03 (d, 1H, J ¼ 8.7 Hz, COACH¼C),
7.24 (d, 1H, J ¼ 9.3 Hz, Furan-H), 7.42–7.84 (m, 4H, Benzo-
fused coumarin-H ), 7.66 (d, 1H, J ¼ 8.7 Hz, COAC¼CH),
8.57 (s, 1H, Coumarin-H). 13C-NMR (CD3OD, 400 Hz): d
183.7 (C¼O), 159.4 (C¼O), 153.0, 151.9, 147.2, 138.9, 138.7,
134.2, 129.3, 128.3, 127.9, 125.4, 118.1, 116.1, 114.1, 109.8.
MS: m/z 300.5 (Mþ, 60%), 199 (80%), 103.5 (38%).
3-(3-(5-Methylfuran-2-yl)acryloyl)-2H-chromen-2-one
(3d). Reagents: Compound 1 (1.0 g, 5.3 mmoles), 5-methyl-
furfural (0.53 mL, 5.3 mmoles), piperidine (0.2 mL). Condi-
tions: MWI for 2.5 min, 140C. Purification: recrystallization
(methylated spirit). kmax (Log e): 208 (4.03), 244 (3.91), 352
(3.42). IR (KBr): 1740, 1685, 1600, 1338 cm1. 1H-NMR
(CD3OD, 400 Hz): d 2.30 (s, 3H, CH3), 6.43 (d, 1H, J ¼ 9.5
Hz, Furan-H), 7.03 (d, 1H, J ¼ 8.5 Hz, COACH¼C), 7.28
(d, 1H, J ¼ 9.5 Hz, Furan-H), 7.42–7.84 (m, 4H, Benzofused
coumarin-H), 7.66 (s, 1H, COAC¼CH). 13C-NMR
(CD3OD, 400 Hz): d 183.7, 159.4, 157.6, 153.0, 152.4, 147.2,
138.9, 134.2, 129.3, 128.3, 127.9, 125.4, 118.1, 117.5,
116.1, 109.5, 13.8 (CH3). MS: m/z 280 (M
þ, 83%), 265
(52%), 68 (30%).
3-(3-(5-Ethylfuran-2-yl)acryloyl)-2H-chromen-2-one (3e). Reagents:
Compound 1 (1.0 g, 5.3 mmoles), 5-ethyl-2-furaldehyde (0.63
mL, 5.3 mmoles), piperidine (0.2 mL). Conditions: MWI for 2
min, 140C. Purification: recrystallization (methylated spirit).
kmax (Log e): 212 (4.07), 248 (3.84), 368 (3.42). IR (KBr):
1734, 1648, 1606, 1380 cm1. 1H-NMR (CD3OD, 400 Hz): d
1.25 (t, 3H, J ¼ 6.0 Hz, CH3), 2.44 (q, 2H, J ¼ 6.0 Hz, CH2),
6.43 (d, 1H, J ¼ 10.0 Hz, Furan-H), 7.03 (d, 1H, J ¼ 8.6 Hz,
COACH¼C), 7.28 (d, 1H, J ¼ 10.0 Hz, Furan-H), 7.42–7.84
(m, 4H, Benzofused coumarin-H), 7.66 (d, 1H, J ¼ 8.6 Hz,
COAC¼CH), 8.57 (s, 1H, Coumarin-H). 13C-NMR (CD3OD,
400 Hz): d 183.7 (C¼O), 159.4 (C¼O), 157.4, 153.0, 151.8,
147.2, 138.9, 134.2, 129.3, 128.3, 127.9, 125.4, 120.0, 118.1,
116.1, 108.7, 21.4 (CH2), 12.7 (CH3). MS: m/z 294 (M
þ,
40%). 280 (45%).
3-(3-(1H-Pyrrol-2-yl)acryloyl-2H-chromen-2-one (4a). Reagents:
Compound 1 (1.0 g, 5.3 mmol), pyrrole-2-carboxaldehyde
(0.50 g, 5.3 mmol), piperidine (0.2 mL). Conditions: MWI for
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2.5 min, 140C. Purification: recrystallization (DMF/ethanol,
1:9). kmax (Log e): 212 (4.16), 344 (3.62). IR (KBr): 3445,
1685, 1600, 1348 cm1. 1H-NMR (CD3OD, 400 Hz): d 5.00
(s, 1H, NH, D2O exchangeable), 6.15 (t, 1H, J ¼ 12.5 Hz, 15
Hz, Pyrrolo-H), 6.51 (d, 1H, J ¼ 12.5 Hz, Pyrrolo-H), 6.95 (d,
1H, J ¼ 15 Hz, Pyrrolo-H), 7.03 (d, 1H, J ¼ 8.0 Hz
COACH¼C), 7.42–7.84 (m, 4H, Benzofused coumarin-H),
7.66 (d, 1H, J ¼ 8.0 Hz, COAC¼CH), 8.57 (s, 1H, Couma-
rin-H). 13C-NMR (CD3OD, 400 Hz): d 183.7, 159.4, 153.0,
147.2, 143.4, 134.2, 129.8, 129.3, 128.3, 127.9, 125.4, 118.3,
118.1, 116.1, 111.9, 108.2. MS: m/s 266 (Mþ, 62%), 199
(100%), 67 (48%).
3-(3-(5-Nitro-1H-pyrrol-2-yl)acryloyl)-2H-chromen-2-one
(4b). Reagents: Compound 1 (1.0 g, 5.3 mmoles), 5-nitro-1H-
pyrrole-2-carboxaldehyde (0.74 g, 5.3 mmoles), piperidine (0.2
mL). Conditions: MWI for 2.5 min, 140C. Purification:
recrystallization (DMF/ethanol, 1:9). kmax (Log e): 210 (3.93),
368 (3.52). IR (KBr): 3302, 1740, 1685, 1600, 1338 cm1. 1H-
NMR (CD3OD, 400 Hz): d 5.0 (s, 1H, NH; D2O exchange-
able), 6.75 (d, 1H, J ¼ 12.3 Hz, Pyrrolo-H), 7.03 (d, 1H, J ¼
7.5 Hz, COACH¼C), 7.42–7.84 (m, 4H, Benzofused couma-
rin-4H), 7.46 (d, 1H, J ¼ 12.3 Hz, Pyrrolo-H), 7.66 (d, 1H, J
¼ 7.5 Hz, COAC¼CH), 8.57 (d, 1H, Coumarin-H). 13C-NMR
(CD3OD, 400 Hz): d 183.7 (C¼O), 159.4 (C¼O), 153.0,
147.2, 143.4, 139.9, 134.2, 134.0, 129.3, 128.3, 127.9, 125.4,
118.1, 116.1, 112.5, 109.3. MS: m/z 311 (Mþ, 55%), 67
(35%).
3-(3-(5-Chloro-1H-pyrrol-2-yl)acryloyl)-2H-chromen-2-one
(4c). Reagents: Compound 1 (1.0 g, 5.3 mmoles), 5-chloro-
1H-pyrrole-2-carboxaldehyde (0.69 g, 5.3 mmoles), piperidine
(0.2 mL). Conditions: MWI for 2.5 min, 140C. Purification:
recrystallization (DMF/ethanol, 3:7). kmax (Log e): 212 (4.29),
252 (3.84), 350 (3.42s). IR (KBr): 3241, 1734, 1685, 1612,
1375, 980 cm1. 1H-NMR (CD3OD, 400 Hz): d 5.0 (s, 1H,
NH; D2O exchangeable), 6.40 (d, 1H, J ¼ 11.2 Hz, Pyrrolo-
H), 6.51 (d, 1H, J ¼ 11.2 Hz, Pyrrolo-H), 7.03 (d, 1H, J ¼ 8.1
Hz, COACH¼C), 7.42–7.84 (m, 4H, Benzofused coumarin-
H), 7.66 (d, 1H, J ¼ 8.1 Hz, COAC¼CH), 8.57 (s, 1H, Cou-
marin-H). 13C-NMR (CD3OD, 400 Hz): d 183.7, 159.4, 153.0,
147.2, 143.4, 134.2, 129.8, 129.3, 128.3, 127.9, 125.4, 121.8,
118.1, 116.3, 116.1, 112.1. MS: m/z 300.5 (Mþ, 55%).
3-(3-(5-Methyl-1H-pyrrol-2-yl)acryloyl)-2H-chromen-2-one
(4d). Reagents: Compound 1 (1.0 g, 5.3 mmoles), 5-methyl-
1H-pyrrole-2-carboxaldehyde (0.58 g, 5.3 mmoles), piperidine
(0.2 mL). Conditions: MWI for 2.5 min, 140C. Purification:
recrystallization (methanol). kmax (Log e): 220 (3.87), 368
(4.15), 388 (3.72). IR (KBr): 3302, 2929, 1734, 1648, 1600,
1375 cm1. 1H-NMR (CD3OD, 400 Hz): d 2.14 (s, 3H, CH3),
5.0 (s, 1H, NH; D2O exchangeable), 6.07 (d, 1H, J ¼ 11.5 Hz,
Pyrrolo-H), 6.35 (d, 1H, J ¼ 11.5 Hz, Pyrrolo-H), 7.03 (d, 1H,
J ¼ 8.1 Hz, COACH¼C), 7.42–7.84 (m, 4H, Benzofused cou-
marin-H), 7.66 (d, 1H, J ¼ 8.1 Hz, COAC¼CH), 8.57 (s, 1H,
Coumarin-H). 13C-NMR (CD3OD, 400 Hz): d 183.7 (C¼O),
159.4 (C¼O), 153.0, 147.2, 143.4, 134.2, 130.1, 129.5, 129.3,
128.3, 127.9, 125.4, 118.1, 116.1, 112.0, 106.5, 17.3 (CH3).
3-(3-(5-ethyl-1H-pyrrol-2-yl)acryloyl)-2H-chromen-2-one
(4e). Reagents: Compound 1 (1.0 g, 5.3 mmoles), 5-ethyl-1H-
pyrrole-2-carboxaldehyde (0.65 g, 5.3 mmoles), piperidine (0.2
mL). Conditions: MWI for 2.5 min, 140C. Purification:
recrystallization (methylated spirit). kmax (Log e): 220 (4.11),
250 (3.91), 368 (3.42). IR (KBr): 3241, 1746, 1740, 1650,
1594, 1375 cm1. 1H-NMR (CD3OD, 400 Hz): d 1.24 (t, 3H,
J ¼ 7.2 Hz, CH3), 3.11 (q, 2H, J ¼ 7.2 Hz, CH2), 5.0 (s, 1H,
NH; D2O exchangeable), 6.07 (d, 1H, J ¼ 11.5 Hz, Pyrrolo-
H), 6.35 (d, 1H, J ¼ 11.5 Hz, Pyrrolo-H), 7.03 (d, 1H, J ¼ 8.2
Hz, COACH¼C), 7.42–7.84 (m, 4H, Benzofused coumarin-
H), 7.66 (d, 1H, J ¼ 8.2 Hz, COAC¼CH), 8.57 (s, 1H, Cou-
marin-H). 13C-NMR (CD3OD, 400 Hz): d 183.7 (C¼O), 159.4
(C¼O), 153.0, 147.2, 143.4, 136.1, 134.2, 129.5, 129.3, 128.3,
127.9, 125.4, 118.1, 116.1, 112.0, 107.7, 21.4 (CH2), 13.7
(CH3).
Antibacterial activity assays. Most of the organisms used
were standard bacteria of National Collection for Industrial
Bacteria (NCIB), whereas few others were Locally Isolated
Organisms (LIO). The organisms were Bacillus cereus (NCIB
6349), Bacillus stearothermophilus (NCIB 8222), Bacillus sub-
tilis (NCIB 3610), Bacillus anthracis (LIO), Bacillus polymyxa
(LIO), Corynebacterium pyogenes (LIO), Streptococcus faeca-
lis (NCIB775), Staphylococcus aureus (NCIB 8588), Clostrid-
ium sporogenes (LIO), Escherichia coli (NCIB 86), Pseudomo-
nas fluorescence (NCIB 3756), Klebsiella pneumonia (NCIB
418), Shigella dysenteriae (LIO), Pseudomonas aeruginosa
(NCIB 950), and Candida albican (LIO).
Antibacterial sensitivity testing of compounds, 1–4e. All
the synthesized compounds (1–4e) and streptomycin were
screened for antibacterial activity on nine gram positive and
five gram negative bacterial strains using agar well diffusion
method [48]. The medium employed was diagnostic sensitivity
test agar (Biotech Ltd.). With the aid of a sterile 1 mL pipette,
about 0.2 mL of the broth culture of test organism was added
to 18 mL sterile molten diagnostic sensitivity test agar (Bio-
tech Ltd.) which had already cooled down to 45C. This was
well mixed and poured into previously sterilized Petri dishes,
which had been properly labeled according to the test organ-
isms. The medium was then allowed to set. With the aid of a
sterile cork borer, the required numbers of holes were bored
into the medium. The wells were made of about 5 mm to the
edge of the plate. The wells were then filled up aseptically
with the solution of the compound in DMSO using Pasteur
pipettes. Streptomycin was used as the standard antibacterial
agent at a concentration of 1000 lg/mL. The plates were
allowed to stand for about 1 h on the bench for proper diffu-
sion of the antibacterial agents into the medium and then incu-
bated uprightly at 37C for 24 h. Care was taken not to stock-
pile the plates. Clear zones of inhibition in millimetres indi-
cated the relative susceptibility of the bacteria to the com-
pounds (1–4e) and streptomycin standard.
Determination of MIC and MBC. The minimum inhibi-
tory concentration (MIC) was done using the method of Rus-
sell and Furr [48]. Based on the level of resistance of some
organisms and large zones of inhibition experienced in others,
minimum inhibitory concentration (MIC) was selectively done
for five gram positive and five gram negative bacterial strains.
Different concentrations (7.8 and 100.0 lg/mL) of the com-
pounds and standard were prepared using a twofold dilution
which was prepared in a sterile plate with the aid of sterile
pipette and then mixed with 18 mL of molten nutrient agar.
This was then allowed to set. The surface of the nutrient agar
plate was allowed to dry before streaking with overnight broth
cultures of the bacterial strains. The plates were then labeled
accordingly and incubated at 37C for up to 72 h. They were
subsequently examined for the presence or absence of growth.
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The lowest concentration preventing the growth of bacteria
was taken as the minimum inhibitory concentration of the
compounds. This procedure was likewise repeated for the
streptomycin (standard).
To obtain minimum bactericidal concentration (MBC), 0.1
mL volume was taken from each tube and spread on agar
plates. The number of c.f.u was counted after 18–24 h of incu-
bation at 35C.
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